Sterling Capital Management LLC Cytokinetics Inc Transaction History
Sterling Capital Management LLC
- $7.3 Trillion
- Q4 2024
A detailed history of Sterling Capital Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Sterling Capital Management LLC holds 3,332 shares of CYTK stock, worth $147,807. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,332
Previous 368
805.43%
Holding current value
$147,807
Previous $19.4 Million
706.68%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$651 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$529 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$477 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$350 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$274 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.18B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...